Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 USD | +4.32% | +3.57% | +61.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 33.33M | Capitalization | 107M |
---|---|---|---|---|---|
Net income 2024 * | -43M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.21 x |
P/E ratio 2024 * |
-2.16
x | P/E ratio 2025 * |
-4.46
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.49% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +2.21% | ||
1 week | +1.09% | ||
Current month | +1.09% | ||
1 month | +15.83% | ||
3 months | +66.47% | ||
6 months | +118.90% | ||
Current year | +54.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 2.895 | +4.14% | 103 399 |
24-06-07 | 2.78 | +2.21% | 117,143 |
24-06-06 | 2.72 | -4.23% | 89,556 |
24-06-05 | 2.84 | -1.05% | 194,094 |
24-06-04 | 2.87 | +2.50% | 214,316 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.44% | 107M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ELDN Stock